A cancer specialist encourages others to follow her example: Own your feelings and don't be afraid to cry. (ASCO Connection)
Many men still don't know that a sexually transmitted disease causes head and neck cancer -- until they have the cancer. (CNN)
Merck announced that a phase III trial showed that treatment with pembrolizumab (Keytruda) improved survival in patients with previously untreated head and neck cancer.
People with colon cancer had a lower risk of disease recurrence and cancer death if they drank artificially sweetened beverages. (Yale Cancer Center, PLoS One)
More evidence that a diet that's heavy on fruits and vegetables lowers the risk of cancer -- specifically breast cancer. (Harvard T. H. Chan School of Public Health, International Journal of Cancer)
Vitamin D supplementation had no effect on cancer risk, according to a study from New Zealand. (JAMA Oncology)
Biotech companies are investing millions to develop cannabinoid products as business data suggest the medical marijuana market will surpass recreational weed as a revenue generator. (Frost & Sullivan)
A possible positive side to the Zika virus: A role in treating an aggressive childhood cancer. (PLoS One, Nemours Children's Health System).
Confirmation that right-sided colon cancer has a worse prognosis as compared with left-sided disease, plus a suggestion for improving outcomes when cancer occurs on the right side. (American College of Surgeons)
Takeda Oncology announced that a phase III trial showed that treatment with brigatinib (Alunbrig) improved progression-free survival in ALK-positive non-small cell lung cancer as compared with crizotinib (Xalkori).
Could radiation therapy for early breast cancer be reduced to a single dose? (UT Southwestern)